论文部分内容阅读
叫停涉事乙肝疫苗湖南两名婴儿在接种深圳康泰生物制品股份有限公司(下称康泰公司)生产的乙肝疫苗后死亡,事件引起各方关注。有网友称,今年11月20日,广东中山一名1个月大的男婴注射乙肝疫苗和卡介苗疫苗,12个小时后意外死亡,涉事的乙肝疫苗也是康泰公司生产的。12月15日,该公司表示,当时它们将当批次乙肝疫苗封存调查,认定为偶合死亡事件,排除疫苗问题,广东省疾控部门也有了相关调查结论。15日,广东省疾控中心证实,11月20日中山男婴死亡与疫苗接种无关。而本次婴儿死亡事件与疫
Stop the matter hepatitis B vaccine Hunan two infants died of the hepatitis B vaccine produced by the Shenzhen Kangtai Biological Products Co., Ltd. (hereinafter referred to as Kangtai company), the incident aroused the attention of all parties. Some netizens said that on November 20 this year, Zhongshan, Guangdong, a one-month-old baby boy was given hepatitis B vaccine and BCG vaccine. After 12 hours of accidental death, the hepatitis B vaccine involved was also produced by Kangtai Company. December 15, the company said that when they will be batches of hepatitis B vaccine sequestration investigation, identified as a coupling deaths, to rule out the vaccine issue, Guangdong CDC also have relevant findings. On the 15th, CDC confirmed that on November 20, Zhongshan’s death was not related to vaccination. This infant death and epidemic